Next Article in Journal
Longitudinal Evaluation of Humoral and Cellular Immunity After BNT162b2 COVID-19 Vaccination: Influence of Booster Type, Infection and Chronic Health Conditions
Next Article in Special Issue
Safety and Cross-Neutralizing Immunity Against SARS-CoV-2 Omicron Sub-Variant After a Booster Dose with SOBERANA® Plus in Children and Adolescents
Previous Article in Journal
The Burden of Pertussis Disease and Vaccination Coverage in Australian Adults Attending Primary Health Care
Previous Article in Special Issue
Integrating Cellular Immune Biomarkers with Machine Learning to Identify Potential Correlates of Protection for a Trypanosoma cruzi Vaccine
 
 
Systematic Review

Article Versions Notes

Vaccines 2025, 13(10), 1030; https://doi.org/10.3390/vaccines13101030
Action Date Notes Link
article html file updated 5 December 2025 19:06 CET Update https://www.mdpi.com/2076-393X/13/10/1030/html
article html file updated 2 October 2025 15:06 CEST Original file -
article supplementary file uploaded. 2 October 2025 15:04 CEST - https://www.mdpi.com/2076-393X/13/10/1030#supplementary
article pdf uploaded. 2 October 2025 15:04 CEST Version of Record https://www.mdpi.com/2076-393X/13/10/1030/pdf
article xml uploaded. 2 October 2025 15:04 CEST Update https://www.mdpi.com/2076-393X/13/10/1030/xml
article xml file uploaded 2 October 2025 15:04 CEST Original file -
Back to TopTop